X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
index medicus (71) 71
female (52) 52
middle aged (52) 52
male (50) 50
prognosis (48) 48
hematology (42) 42
aged (38) 38
gene expression profiling (35) 35
hemic and lymphatic diseases (32) 32
adult (31) 31
gene expression (30) 30
lymphoma, large b-cell, diffuse - genetics (29) 29
lymphoma, large b-cell, diffuse - drug therapy (27) 27
cancer (25) 25
oncology (24) 24
immune system diseases (23) 23
survival (23) 23
expression (22) 22
lymphomas (22) 22
gene expression regulation, neoplastic (21) 21
rituximab (21) 21
aged, 80 and over (20) 20
lymphoma, large b-cell, diffuse - mortality (20) 20
cell line, tumor (19) 19
lymphoma, large b-cell, diffuse - metabolism (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
lymphoma, large b-cell, diffuse - pathology (18) 18
analysis (17) 17
dlbcl (16) 16
chemotherapy (15) 15
diffuse large b-cell lymphoma (15) 15
gene-expression (15) 15
immunohistochemistry (15) 15
research (15) 15
animals (14) 14
hematology, oncology and palliative medicine (14) 14
research article (14) 14
transcriptome (14) 14
treatment outcome (14) 14
classification (13) 13
cyclophosphamide - therapeutic use (13) 13
abridged index medicus (12) 12
b-cell lymphoma (12) 12
genetic aspects (12) 12
lymphocytes b (12) 12
lymphoid neoplasia (12) 12
medicine (12) 12
oligonucleotide array sequence analysis (12) 12
pathology (12) 12
survival analysis (12) 12
young adult (12) 12
adolescent (11) 11
b-lymphocytes - metabolism (11) 11
disease-free survival (11) 11
doxorubicin - therapeutic use (11) 11
multidisciplinary sciences (11) 11
prednisone - therapeutic use (11) 11
tumor suppressor protein p53 - genetics (11) 11
vincristine - therapeutic use (11) 11
antibodies, monoclonal, murine-derived - therapeutic use (10) 10
development and progression (10) 10
differentiation (10) 10
lymphoma (10) 10
medical research (10) 10
multiple myeloma (10) 10
mutation (10) 10
retrospective studies (10) 10
science (10) 10
apoptosis (9) 9
biomarkers (9) 9
genetics (9) 9
health aspects (9) 9
lymphoma, large b-cell, diffuse - diagnosis (9) 9
reproducibility of results (9) 9
article (8) 8
b-lymphocyte subsets - metabolism (8) 8
bcl2 (8) 8
cell biology (8) 8
chop consortium program (8) 8
diagnosis (8) 8
genes (8) 8
immunology (8) 8
immunophenotyping (8) 8
kaplan-meier estimate (8) 8
b cells (7) 7
cluster analysis (7) 7
cyclophosphamide (7) 7
cyclophosphamide - administration & dosage (7) 7
dna (7) 7
doxorubicin - administration & dosage (7) 7
drug resistance, neoplasm (7) 7
journal article (7) 7
micrornas - genetics (7) 7
pathogenesis (7) 7
prednisone - administration & dosage (7) 7
r-chop (7) 7
risk factors (7) 7
rituximab-chop (7) 7
tissue array analysis (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0138236
Journal Article
Haematologica, ISSN 0390-6078, 02/2013, Volume 98, Issue 2, pp. 255 - 263
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, p. e0190709
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1623 - 1623
Background: Patients with Diffuse large B-cell lymphoma (DLBCL) in approximately 40% of cases suffer from primary refractory disease and treatment induced... 
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, pp. e0153069 - e0153069
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, pp. e0169286 - e0169286
Background Toxicity of the oral and gastrointestinal mucosa induced by high-dose melphalan is a clinical challenge with no documented prophylactic... 
MATRIX METALLOPROTEINASES | CYTOTOXIC CHEMOTHERAPY | CYCLOOXYGENASE-2 COX-2 EXPRESSION | INDUCTION THERAPY | MULTIDISCIPLINARY SCIENCES | BEAM-CONDITIONING CHEMOTHERAPY | SMALL-INTESTINE | RECEPTOR | STEM-CELL TRANSPLANTATION | NF-KAPPA-B | CANCER-THERAPY | Immunohistochemistry | Follow-Up Studies | Humans | Middle Aged | Gene Expression Regulation | Mouth Mucosa - immunology | Hematopoietic Stem Cell Transplantation | Male | Stomatitis - immunology | Stomatitis - blood | HLA-DRB5 Chains - immunology | Dose-Response Relationship, Drug | Mouth Mucosa - metabolism | Melphalan - administration & dosage | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Biopsy | Stomatitis - chemically induced | Female | Stomatitis - genetics | Aged | Mouth Mucosa - pathology | Medical research | Care and treatment | Dendritic cells | Genes | Multiple myeloma | HLA histocompatibility antigens | Gene expression | Histocompatibility antigens | Analysis | Melphalan | Medicine, Experimental | Dosage and administration | Genetic aspects | Tumor proteins | Cancer | Alternative splicing | Disease | Toxicity | Identification methods | Mucosa | p53 Protein | Gene regulation | Genomes | Cancer therapies | Blood | Subgroups | Receptors | Lasers | Quality | Drb1 protein | Tumor necrosis factor-TNF | Drug dosages | Deoxyribonucleic acid--DNA | Antigens | MDM2 protein | Mucositis | Psoriasis | Hematology | Immunoregulation | Metabolism | Patients | Medicine | Pathology | Chemotherapy | Hospitals | Tumor necrosis factor | Stem cells | Biomarkers | Histocompatibility antigen HLA | Clinical medicine | Apoptosis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Infectious Diseases in Obstetrics and Gynecology, ISSN 1064-7449, 2016, Volume 2016, pp. 3086036 - 19
Based on the current literature, we aimed to provide an overview on Human Papillomavirus prevalence in normal pregnancies and pregnancies with adverse outcome.... 
Pregnancy | Papillomavirus Infections - complications | Pregnancy Complications, Infectious - virology | Humans | Premature Birth - virology | Abortion, Spontaneous - virology | Female | Analysis | Research | Abortion | Papillomavirus infections | Health aspects | Premature labor | Risk factors | Prevalence studies (Epidemiology) | Review
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2014, Volume 20, Issue 9, pp. 2338 - 2349
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 335 - 11
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with diverse clinical presentation and outcome. Bio-clinical prognostic models including... 
SURVIVAL | MULTIDISCIPLINARY SCIENCES | RESISTANCE | CLASSIFICATION | MUTATIONS | SUBSET | CANCER | Alternative splicing | Lymphocytes B | Transcription | Medical prognosis | Phenotyping | Biomarkers | Tumorigenesis | Lymphomas | Vincristine | B-cell lymphoma
Journal Article